US 6660719
Inhibiting T-Cell proliferation
expired A61KA61K31/00A61K31/519
Quick answer
US patent 6660719 (Inhibiting T-Cell proliferation) held by BioCryst Pharmaceuticals, Inc. expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/00, A61K31/519, A61K31/708